Sorry, this section is only available in Japanese.

前のページに戻るこの文献は全文を取り寄せることができます

JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。

既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方

JDreamⅢ複写サービス
文献複写のお申込み

JDreamⅢ複写サービスのご利用が初めての方

学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内

取り寄せる文献のタイトルと詳細

文献

J-GLOBAL ID：202002215690933497 整理番号：20A2344581

エフェクターと制御性T細胞間のPD-1発現バランスはPD-1遮断療法の臨床的有効性を予測する【JST・京大機械翻訳】

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

著者 (36件)：

Kumagai Shogo

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Kumagai Shogo

(Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Togashi Yosuke

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Kamada Takahiro

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Kamada Takahiro

(Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Sugiyama Eri

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Sugiyama Eri

(Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Nishinakamura Hitomi

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Takeuchi Yoshiko

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Vitaly Kochin

(Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Itahashi Kota

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Maeda Yuka

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Matsui Shigeyuki

(Department of Biostatics, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Shibahara Takuma

(Research and Development Group, Hitachi Ltd., Tokyo, Japan)

Yamashita Yasuho

(Research and Development Group, Hitachi Ltd., Tokyo, Japan)

Irie Takuma

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Tsuge Ayaka

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Tsuge Ayaka

(Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Fukuoka Shota

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Kawazoe Akihito

(Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan)

Udagawa Hibiki

(Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan)

Kirita Keisuke

(Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan)

Aokage Keiju

(Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan)

Ishii Genichiro

(Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan)

Kuwata Takeshi

(Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan)

Nakama Kenta

(Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan)

Kawazu Masahito

(Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan)

Ueno Toshihide

(Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan)

Yamazaki Naoya

(Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan)

Goto Koichi

(Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan)

Tsuboi Masahiro

(Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan)

Mano Hiroyuki

(Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan)

Doi Toshihiko

(Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan)

Shitara Kohei

(Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan)

Nishikawa Hiroyoshi

(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Chiba, Japan)

Nishikawa Hiroyoshi

(Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan)

資料名：

Nature Immunology (Nature Immunology)

巻： 21 号： 11 ページ： 1346-1358 発行年： 2020年
JST資料番号： W1330A ISSN： 1529-2908 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：ドイツ (DEU) 言語：英語 (EN)

JDreamⅢ複写サービスとは

JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

TOP

BOTTOM